Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
NCT04860141
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Dental Pain and Sensation Disorder
- Pain, Postoperative
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 to 59 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Loma Linda University
- Last updated on ClinicalTrials.gov
- February 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Loma Linda University Health · Loma Linda, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.